PS
IMGN

Principal Securities’s Immunogen Inc IMGN Stock Holding History

Principal Securities’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-324
Closed -$9.61K – 3411
2023
Q4 		$9.61K Buy
+324
New +$6.45K ﹤0.01% 2262

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Principal Securities's IMGN Position: Q1 2024 in Review

Principal Securities sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 324 shares — an estimated $9.61K sold.

Principal Securities first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $9.61K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Principal Securities reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Principal Securities sold 324 Immunogen Inc shares in Q1 2024, an estimated $9.61K.
  • Principal Securities first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Principal Securities's Immunogen Inc position peaked at $9.61K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Principal Securities's 13F filing for Q1 2024, filed 10 May 2024.